Metrics
1 Record Views
- Title
- Updated Results from a Phase 1 Study of APVO436, a Novel Bispecific Anti-CD123 x Anti-CD3 Adaptir™ Molecule, in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Creators
- Justin Watts - Sylvester Comprehensive Cancer CenterMichael Maris - Sarah CannonTara L. Lin - University of KansasPrapti Patel - ServierYazan F. Madanat - The University of Texas Southwestern Medical CenterChristopher R. Cogle - University of FloridaGautam Borthakur - The University of Texas MD Anderson Cancer CenterDirk Huebner - Aptevo Theraputics, Seattle, WANoor Khaskhely - Aptevo Theraputics, Seattle, WALynn Bonham - Aptevo Theraputics, Seattle, WAMonica Massaro - Aptevo Theraputics, Seattle, WADaphne Taylor - Aptevo Theraputics, Seattle, WACaroline Taromino - Aptevo Theraputics, Seattle, WAAlice S. Mims - The Ohio State University
- Publication Details
- Blood, Vol.140(Supplement 1), pp.6204-6205
- Publisher
- Elsevier Inc; AMSTERDAM
- Number of pages
- 2
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032860763002976